SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-130060
Filing Date
2022-04-29
Accepted
2022-04-29 07:06:52
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d235425ddefa14a.htm DEFA14A 13622
2 GRAPHIC g235425g54q39.jpg GRAPHIC 288348
3 GRAPHIC g235425g55s37.jpg GRAPHIC 266848
  Complete submission text file 0001193125-22-130060.txt   779390
Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Filer) CIK: 0001658551 (see all company filings)

IRS No.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41199 | Film No.: 22870081
SIC: 2834 Pharmaceutical Preparations